{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T22:45:37Z","timestamp":1759099537455},"reference-count":50,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.autrev.2013.08.003","type":"journal-article","created":{"date-parts":[[2013,9,2]],"date-time":"2013-09-02T01:45:20Z","timestamp":1378086320000},"page":"70-72","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Letter to the Editor in response to the article \u201cPreventing congenital neonatal heart block in offspring of mothers with anti-SSA\/Ro and SSB\/La antibodies: A review of published literature and registered clinical trials.\u201d by Gleicher N, Elkayam U, Autoimmun Rev. 2013 Sep;12(11):1039-45"],"prefix":"10.1016","volume":"13","author":[{"given":"Nathalie","family":"Costedoat-Chalumeau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Izmirly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Wahren-Herlenius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Earl","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Brucato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Boutjdir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munther","family":"Khamashta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Llanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia N.","family":"Pisoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah M.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Clancy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin K.L.","family":"Phoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill P.","family":"Buyon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2013.08.003_bb0005","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.autrev.2013.04.006","article-title":"Preventing congenital neonatal heart block in offspring of mothers with anti-SSA\/Ro and SSB\/La antibodies: a review of published literature and registered clinical trials","volume":"12","author":"Gleicher","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.08.003_bb0010","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/ar3787","article-title":"Congenital heart block: evidence for a pathogenic role of maternal autoantibodies","volume":"14","author":"Ambrosi","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2013.08.003_bb0015","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/BOR.0b013e328356226b","article-title":"Neonatal lupus: advances in understanding pathogenesis and identifying treatments of cardiac disease","volume":"24","author":"Izmirly","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2013.08.003_bb0020","series-title":"Systemic lupus erythematosus","first-page":"541","article-title":"Neonatal lupus","author":"Buyon","year":"2010"},{"key":"10.1016\/j.autrev.2013.08.003_bb0025","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1002\/art.22157","article-title":"Antimalarial agents: closing the gate on toll-like receptors?","volume":"54","author":"Lafyatis","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.08.003_bb0030","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/ard.2008.088054","article-title":"Disease progression in mothers of children enrolled in the Research Registry for Neonatal Lupus","volume":"68","author":"Rivera","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2013.08.003_bb0035","doi-asserted-by":"crossref","first-page":"544","DOI":"10.7326\/0003-4819-120-7-199404010-00003","article-title":"Autoantibody-associated congenital heart block: outcome in mothers and children","volume":"120","author":"Waltuck","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2013.08.003_bb0040","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C","article-title":"Risk of congenital complete heart block in newborns of mothers with anti-Ro\/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women","volume":"44","author":"Brucato","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.08.003_bb0045","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIRCULATIONAHA.111.033894","article-title":"Maternal and fetal factors associated with mortality and morbidity in a multi-racial\/ethnic registry of anti-SSA\/Ro-associated cardiac neonatal lupus","volume":"124","author":"Izmirly","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2013.08.003_bb0050","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0002-9343(97)89492-2","article-title":"Long-term outcome of mothers of children with complete congenital heart block","volume":"100","author":"Press","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2013.08.003_bb0055","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/1529-0131(200103)44:3<647::AID-ANR113>3.0.CO;2-I","article-title":"Long-term outcome of mothers of children with isolated heart block in Finland","volume":"44","author":"Julkunen","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.08.003_bb0060","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1172\/JCI117025","article-title":"Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro\/SSA-positive patients in rabbit hearts","volume":"93","author":"Garcia","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2013.08.003_bb0065","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/annrheumdis-2011-200414","article-title":"Anti-Ro52 monoclonal antibodies specific for amino acid 200\u2013239, but not other Ro52 epitopes, induce congenital heart block in a rat model","volume":"71","author":"Ambrosi","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2013.08.003_bb0070","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/01.RES.80.3.354","article-title":"Arrhythmogenicity of IgG and anti-52-kD SSA\/Ro affinity-purified antibodies from mothers of children with congenital heart block","volume":"80","author":"Boutjdir","year":"1997","journal-title":"Circ Res"},{"key":"10.1016\/j.autrev.2013.08.003_bb0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1203\/00006450-199807000-00002","article-title":"Serum and immunoglobulin G from the mother of a child with congenital heart block induce conduction abnormalities and inhibit L-type calcium channels in a rat heart model","volume":"44","author":"Boutjdir","year":"1998","journal-title":"Pediatr Res"},{"key":"10.1016\/j.autrev.2013.08.003_bb0080","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1203\/01.PDR.0000155947.82365.E4","article-title":"Effect of maternal autoantibodies on fetal cardiac conduction: an experimental murine model","volume":"57","author":"Suzuki","year":"2005","journal-title":"Pediatr Res"},{"key":"10.1016\/j.autrev.2013.08.003_bb0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1084\/jem.20041859","article-title":"Ro\/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block","volume":"201","author":"Salomonsson","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2013.08.003_bb0090","first-page":"2413","article-title":"Impaired clearance of apoptotic cardiocytes is linked to anti-SSA\/Ro and -SSB\/La antibodies in the pathogenesis of congenital heart block","volume":"116","author":"Clancy","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2013.08.003_bb0095","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/uog.1919","article-title":"Prenatal diagnosis of complete atrioventricular block associated with structural heart disease: combined experience of two tertiary care centers and review of the literature","volume":"26","author":"Jaeggi","year":"2005","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.autrev.2013.08.003_bb0100","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0735-1097(01)01697-7","article-title":"Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution's experience of 30years","volume":"39","author":"Jaeggi","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2013.08.003_bb0105","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.jacc.2006.07.034","article-title":"Presentation and prognosis of complete atrioventricular block in childhood, according to maternal antibody status","volume":"48","author":"Villain","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2013.08.003_bb0110","first-page":"183","article-title":"Autoimmune response in mothers of children with congenital and postnatally diagnosed isolated heart block: a population based study","volume":"31","author":"Julkunen","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2013.08.003_bb0115","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/annrheumdis-2011-200207","article-title":"Development of heart block in children of SSA\/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern","volume":"71","author":"Ambrosi","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2013.08.003_bb0120","doi-asserted-by":"crossref","first-page":"64 e1-7","DOI":"10.1016\/j.ajog.2012.09.020","article-title":"Maternal autoantibody levels in congenital heart block and potential prophylaxis with antiinflammatory agents","volume":"208","author":"Tunks","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.autrev.2013.08.003_bb0125","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1067\/mpd.2003.233","article-title":"Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies","volume":"142","author":"Cimaz","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.autrev.2013.08.003_bb0130","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1002\/art.20554","article-title":"Outcome of pregnancies in patients with anti-SSA\/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group","volume":"50","author":"Costedoat-Chalumeau","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.08.003_bb0135","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/rheumatology\/kem073","article-title":"Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases\u2014a multicentre prospective study","volume":"46","author":"Gerosa","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2013.08.003_bb0140","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/sj.jp.7211688","article-title":"Outcome of infants from mothers with anti-SSA\/Ro antibodies","volume":"27","author":"Motta","year":"2007","journal-title":"J Perinatol"},{"key":"10.1016\/j.autrev.2013.08.003_bb0145","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1002\/art.24768","article-title":"Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal\/fetal risk factors","volume":"60","author":"Llanos","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.08.003_bb0150","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.3899\/jrheum.080737","article-title":"Congenital heart block not associated with anti-Ro\/La antibodies: comparison with anti-Ro\/La-positive cases","volume":"36","author":"Brucato","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2013.08.003_bb0155","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/art.11430","article-title":"Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage\/fibroblast crosstalk in the pathologic cascade leading to congenital heart block","volume":"50","author":"Clancy","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.08.003_bb0160","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/art.20126","article-title":"Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA\/Ro 52-kd antibodies","volume":"50","author":"Sonesson","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.08.003_bb0165","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/CIRCULATIONAHA.107.707661","article-title":"Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study","volume":"117","author":"Friedman","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2013.08.003_bb0170","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/1529-0131(199911)42:11<2335::AID-ANR12>3.0.CO;2-3","article-title":"Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus","volume":"42","author":"Saleeb","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.08.003_bb0175","first-page":"373","article-title":"Primary Sjogren's syndrome\u2014treatment of fetal incomplete atrioventricular block with dexamethasone","volume":"28","author":"Theander","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2013.08.003_bb0180","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1161\/CIRCULATIONAHA.108.773143","article-title":"Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA\/Ro-SSB\/La antibodies: a prospective, observational, fetal kinetocardiogram-based study","volume":"119","author":"Rein","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2013.08.003_bb0185","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-3083.2010.02440.x","article-title":"The benefits of transplacental treatment of isolated congenital complete heart block associated with maternal anti-Ro\/SSA antibodies: a review","volume":"72","author":"Hutter","year":"2010","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2013.08.003_bb0190","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/ard.62.10.1010","article-title":"Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block","volume":"62","author":"Costedoat-Chalumeau","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2013.08.003_bb0195","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/art.27308","article-title":"Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: results of a multicenter, prospective, open-label clinical trial","volume":"62","author":"Friedman","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.08.003_bb0200","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/art.27350","article-title":"Failure of intravenous immunoglobulin to prevent congenital heart block: findings of a multicenter, prospective, observational study","volume":"62","author":"Pisoni","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.08.003_bb0205","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2009.119263","article-title":"Evaluation of the risk of anti-SSA\/Ro-SSB\/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine","volume":"69","author":"Izmirly","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2013.08.003_bb0210","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.089268","article-title":"Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA\/Ro-antibody-associated cardiac manifestations of neonatal lupus","volume":"126","author":"Izmirly","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2013.08.003_bb0215","first-page":"1862","article-title":"The increasing incidence of isolated congenital heart block in Finland","volume":"25","author":"Siren","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2013.08.003_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","article-title":"Optimal two-stage designs for phase II clinical trials","volume":"10","author":"Simon","year":"1989","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.autrev.2013.08.003_bb0225","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.autrev.2004.11.009","article-title":"Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature","volume":"4","author":"Costedoat-Chalumeau","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.08.003_bb0230","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.reprotox.2013.04.005","article-title":"Pregnancy outcome following in utero exposure to hydroxychloroquine: a prospective comparative observational study","volume":"39C","author":"Diav-Citrin","year":"2013","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.autrev.2013.08.003_bb0235","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.3899\/jrheum.110686","article-title":"Ocular toxicity in children exposed in utero to antimalarial drugs: review of the literature","volume":"38","author":"Osadchy","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2013.08.003_bb0240","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1002\/art.22159","article-title":"Hydroxychloroquine in lupus pregnancy","volume":"54","author":"Clowse","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.08.003_bb0245","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1191\/096120301678646137","article-title":"Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study","volume":"10","author":"Levy","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2013.08.003_bb0250","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/rheumatology\/keq350","article-title":"Pregnancy and reproduction in autoimmune rheumatic diseases","volume":"50","author":"Ostensen","year":"2011","journal-title":"Rheumatology (Oxford)"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997213001481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997213001481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T09:22:20Z","timestamp":1539422540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997213001481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1568997213001481"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2013.08.003","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Letter to the Editor in response to the article \u201cPreventing congenital neonatal heart block in offspring of mothers with anti-SSA\/Ro and SSB\/La antibodies: A review of published literature and registered clinical trials.\u201d by Gleicher N, Elkayam U, Autoimmun Rev. 2013 Sep;12(11):1039-45","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2013.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2013.04.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}